Sequent Scientific Ltd. | Mutual Funds
Mutual Funds that own Sequent Scientific Ltd.
SBI Magnum Taxgain Scheme - 1993
3,500,000
1.44%
0
0.38%
06/30/2018
SBI Pharma Fund
3,000,000
1.23%
0
1.98%
06/30/2018
SBI Magnum Mid Cap Fund
2,922,019
1.2%
0
0.56%
06/30/2018
SBI Magnum Multiplier Plus Scheme - 1993
1,617,358
0.66%
0
0.49%
06/30/2018
SPDR S&P Emerging Markets ETF
293,648
0.12%
0
0.02%
09/06/2018
SPDR S&P Emerging Asia Pacific ETF
129,901
0.05%
0
0.03%
09/06/2018
SBI Magnum Children's Benefit Plan
75,000
0.03%
0
1.43%
05/31/2018
CREF Stock Account
54,469
0.02%
0
0%
03/31/2018
DFA Emerging Markets Core Equity Portfolio
33,861
0.01%
0
0%
04/30/2018
DFA Emerging Markets Small Cap Series
15,341
0.01%
8,361
0%
01/31/2018
| Address |
301/A, Dosti Pinnacle
Mumbai Maharashtra 400604
India
|
|
Employees
|
- |
| Website |
http://www.sequent.in |
| Updated |
09/14/2018 |
| SeQuent Scientific Ltd. engages in the manufacture of active pharmaceutical ingredients for the animal health sector. It offers nonsteroidal anti-inflammatory drugs, antibiotics, anthelmintics, vitamins, prostaglandins, and hormonal. It operates through the following geographical segments: Europe, Asia, and Rest of World. |
